Would Expanded Lab-Test Regulation Overstep FDA’s Legal Limits?
This article was originally published in The Gray Sheet
Executive Summary
Efforts to alter the way laboratory tests are regulated highlight the need to better define FDA's authority over certain medical products
You may also be interested in...
What's Next For LDTs? FDA May Be Eyeing A New Game Plan
Following the agency's signal to stakeholders that it will not be finalizing a regulatory framework for laboratory-developed tests this year, industry experts suggest some other approaches FDA could take to address lab tests of all stripes.
Lab Groups’ LDT Comments Will Highlight Barriers To Test Accessibility
Laboratory groups, who are facing the prospect of a new regulatory scheme in FDA’s proposed lab-developed test framework, intend to discuss barriers to test accessibility and clinical validation of LDTs.
Lab Groups’ LDT Comments Will Highlight Barriers To Test Accessibility
Laboratory groups, who are facing the prospect of a new regulatory scheme in FDA’s proposed lab-developed test framework, intend to discuss barriers to test accessibility and clinical validation of LDTs in future comments.